Effectiveness of phytoestrogens in climacteric medicine

Annals of the New York Academy of Sciences

Volumn 1205, Issue , 2010, Pages 262-267

  Al Azzawi, Farook ^a   Wahab, May ^b  

^a UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

^b GEORGE ELIOT HOSPITAL   (United Kingdom)

Author keywords

breast cancer; climacteric; hot flushes; menopause; phytoestrogen

Indexed keywords

CLONIDINE; COUMESTAN; DAIDZEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN RECEPTOR; FLAVANOID; GENISTEIN; GESTAGEN; ISOFLAVONE DERIVATIVE; LIGNAN DERIVATIVE; PHYTOALEXIN; PHYTOESTROGEN; PLACEBO; PRENYL FLAVONOID; PROTEIN TYROSINE KINASE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TAMOXIFEN; UNCLASSIFIED DRUG;

APOPTOSIS; ASIAN; BREAST CANCER; CANCER CELL; CANCER PREVENTION; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; CARCINOGENICITY; CELL GROWTH; CELL PROLIFERATION; CLIMACTERIUM; COHORT ANALYSIS; CONFERENCE PAPER; DIET SUPPLEMENTATION; DIETARY INTAKE; DRUG BIOAVAILABILITY; DRUG METABOLISM; ENZYME INHIBITION; ESTROGEN DEFICIENCY; EXPOSURE; FATIGUE; GENOMICS; GLYCOSYLATION; HOST RESISTANCE; HOT FLUSH; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INGESTION; MAMMOGRAPHY; MEMORY; MENOPAUSAL SYNDROME; MENTAL CONCENTRATION; MOLECULAR INTERACTION; NONHUMAN; ONCOGENE C FOS; OXIDATIVE STRESS; PLANT CELL; QUALITY OF LIFE; RECURRENCE RISK; RISK ASSESSMENT; SIGNAL TRANSDUCTION; SLEEP DISORDER; SOYBEAN; SWEATING; TABLET; TRANSGENIC MOUSE; TUMOR BIOPSY; VASOMOTOR DISORDER; BREAST; BREAST NEOPLASMS; CHEMISTRY; DRUG EFFECTS; EVALUATION STUDY; FEMALE; MEDICINE; PATHOLOGY; PHYSIOLOGY; PROCEDURES; RECURRENT DISEASE; TREATMENT OUTCOME; TRENDS;

BREAST; BREAST NEOPLASMS; CLIMACTERIC; FEMALE; HUMANS; MEDICINE; PHYTOESTROGENS; RECURRENCE; TREATMENT OUTCOME;

EID: 77957072883     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2010.05678.x     Document Type: Conference Paper

References (40)

1. Murkies, A.L., G.Wilcox & S.R. Davis.1998. Clinical review 92: phytoestrogens. J. Clin. Endocrinol. Metab. 83: 297-303.
2. Dixon, R.A. & N.L. Paiva. 1995. Stress-induced phenylpropanoid metabolism. Plant Cell 7: 1085-1097.
3. Woo, H.H., B.R. Jeong & M.C. Hawes. 2005. Flavonoids: from cell cycle regulation to biotechnology. Biotechnol. Lett. 27: 365-374.
4. Maki, P.M. et al. 2009. Effects of botanicals and combined hormone therapy on cognition in postmenopausal women. Menopause 16: 1167-1177.
5. Anderson, G.L. et al. 2004. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Womens Health Initiative randomized controlled trial. JAMA 291: 1701-1712.
6. Adlercreutz, H., S.M. Heinonen & J. Penalvo-Garcia. 2004. Phytoestrogens, cancer and coronary heart disease. Biofactors 22: 229-236.
7. Kousidou,O., G.N. Tzanakakis&N.K. Karamanos. 2006. Effects of the natural isoflavonoid genistein on growth, signaling pathways and gene expression of matrix macromolecules by breast cancer cells. Mini Rev. Med. Chem. 6: 331-337.
8. Schultze-Mosgau, M.H. et al. 1998. Regulation of c-fos transcription by chemopreventive isoflavonoids and lignans in MDA-MB-468 breast cancer cells. Eur. J. Cancer 34: 1425-1431.
9. De Lemos, M.L. 2001. Effects of soy phytoestrogens genistein and daidzein on breast cancer growth. Ann. Pharmacother. 35: 1118-1121.
10. Magee, P.J. & I.R. Rowland. 2004. Phyto-oestrogens, their mechanism of action: current evidence for a role in breast and prostate cancer. Br. J. Nutr. 91: 513-531.
11. McMichael-Phillips, D.F. et al. 1998. Effects of soy-protein supplementation on epithelial proliferation in the histologically normal human breast. Am. J. Clin.Nutr. 68(6 Suppl.): 1431S-1435S.
12. Velentzis, L.S. et al. 2008. Do phytoestrogens reduce the risk of breast cancer and breast cancer recurrence? What clinicians need to know. Eur. J. Cancer 44: 1799-1806.
13. Wu, A.H. et al. 1998. Soy intake and risk of breast cancer in Asians and Asian Americans. Am. J. Clin. Nutr. 68(6 Suppl.): 1437S-1443S.
14. Horn-Ross, P.L. et al. 2002. Recent diet and breast cancer risk: the California Teachers Study (USA). Cancer Causes Control 13: 407-415.
15. Den Tonkelaar, I. et al. 2001. Urinary phytoestrogens and postmenopausal breast cancer risk. Cancer Epidemiol. Biomarkers Prev. 10: 223-228.
16. Horn-Ross, P.L. 2001. Assessing phytoestrogen exposure via a food-frequency questionnaire. Cancer Causes Control 12: 477-478.
17. Ziegler, R.G. 2004. Phytoestrogens and breast cancer. Am. J. Clin. Nutr. 79: 183-184.
18. Hulten, K. et al. 2002. An incident case-referent study on plasma enterolactone and breast cancer risk. Eur. J. Nutr. 41: 168-176.
19. Trock, B.J., L. Hilakivi-Clarke & R. Clarke. 2006. Metaanalysis of soy intake and breast cancer risk. J. Natl. Cancer Inst. 98: 459-471.
20. Hilakivi-Clarke, L. et al. 1999. Prepubertal exposure to zearalenone or genistein reduces mammary tumorigenesis. Br. J. Cancer 80: 1682-1688.
21. Lamartiniere, C.A. 2002. Timing of exposure andmammary cancer risk. J. Mammary Gland Biol. Neoplasia 7: 67-76.
22. Wu, A.H. et al. 2002. Adolescent and adult soy intake and risk of breast cancer in Asian-Americans. Carcinogenesis 23: 1491-1496.
23. Thanos, J. et al. 2006. Adolescent dietary phytoestrogen intake and breast cancer risk (Canada). Cancer Causes Control 17: 1253-1261.
24. Jakes, R.W. et al. 2002. Mammographic parenchymal patterns and self-reported soy intake in Singapore Chinese women. Cancer Epidemiol. Biomarkers Prev. 11: 608-613.
25. Maskarinec, G. et al. 2004. A 2-year soy intervention in premenopausal women does not change mammographic densities. J. Nutr. 134: 3089-3094.
26. Maskarinec, G. et al. 2006. A longitudinal investigation of mammographic density: themultiethnic cohort. Cancer Epidemiol. Biomarkers Prev. 15: 732-739.
27. Quella, S.K. et al. 2000. Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors: a North Central Cancer Treatment Group Trial. J. Clin. Oncol. 18: 1068-1074.
28. Van Patten, C.L. et al. 2002. Effect of soy phytoestrogens on hot flashes in postmenopausal women with breast cancer: a randomized, controlled clinical trial. J. Clin. Oncol. 20: 1449-1455.
29. Nikander, E. et al. 2003. A randomized placebo-controlled crossover trial with phytoestrogens in treatment of menopause in breast cancer patients. Obstet. Gynecol. 101: 1213-1220.
30. MacGregor, C.A. et al. 2005. A randomised double-blind controlled trial of oral soy supplements versus placebo for treatment of menopausal symptoms in patients with early breast cancer. Eur. J. Cancer 41: 708-714.
31. Jacobson, J.S. et al. 2001. Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer. J. Clin. Oncol. 19: 2739-2745.
32. Pockaj, B.A. et al. 2006. Phase III double-blind, randomized, placebo-controlled crossover trial of black cohosh in the management of hot flashes: NCCTG Trial N01CC1. J. Clin. Oncol. 24: 2836-2841.
33. Constantinou, A.I., A.E. Krygier & R.R.Mehta. 1998. Genistein induces maturation of cultured human breast cancer cells and prevents tumor growth in nude mice. Am. J. Clin. Nutr. 68(6 Suppl.): 1426S-1430S.
34. Ju, Y.H. et al. 2006. Genistein stimulates growth of human breast cancer cells in a novel, postmenopausal animal model, with lowplasma estradiol concentrations. Carcinogenesis 27: 1292-1299.
35. Boyapati, S.M. et al. 2005. Soyfood intake and breast cancer survival: a followup of the Shanghai Breast Cancer Study. Breast Cancer Res. Treat. 92: 11-17.
36. Thompson, L.U. et al. 2005. Dietary flaxseed alters tumor biological markers in postmenopausal breast cancer. Clin. Cancer Res. 11: 3828-3835.
37. Schwartz, J.A., G. Liu & S.C. Brooks. 1998. Genisteinmediated attenuation of tamoxifen-induced antagonism from estrogen receptor-regulated genes. Biochem. Biophys. Res. Commun. 253: 38-43.
38. Liu, B. et al. 2005. Low-dose dietary phytoestrogen abrogates tamoxifen-associated mammary tumor prevention. Cancer Res. 65: 879-886.
39. This, P. et al. 2001. Phytoestrogens after breast cancer. Endocr. Relat. Cancer 8: 129-134.
40. Brooks, J.D. & L.U. Thompson. 2005. Mammalian lignans and genistein decrease the activities of aromatase and 17betahydroxysteroid dehydrogenase in MCF-7 cells. J. Steroid Biochem. Mol. Biol. 94: 461-467.